Prof Fred Hirsch - University of Colorado, Denver
Prof Fred Hirsch speaks about the shift towards individualised medication within the treatment of lung cancer. He outlines the role of genetic mutations, the progress that has been made developing new biomarkers, and recent developments in the chemo-prevention of lung cancer.